A detailed history of Israel Englander (Millennium Management LLC) transactions in Legend Biotech Corp stock. As of the latest transaction made, Millennium Management LLC holds 570,376 shares of LEGN stock, worth $19.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
570,376
Previous 80,000 612.97%
Holding current value
$19.4 Million
Previous $3.54 Million 684.48%
% of portfolio
0.01%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$43.55 - $59.88 $47.4 Million - $65.2 Million
-1,088,305 Reduced 65.61%
570,376 $27.8 Million
Q2 2024

Aug 14, 2024

BUY
$39.5 - $57.22 $50.9 Million - $73.7 Million
1,287,590 Added 346.97%
1,658,681 $73.5 Million
Q1 2024

May 15, 2024

SELL
$55.06 - $69.99 $11.6 Million - $14.8 Million
-211,059 Reduced 36.26%
371,091 $20.8 Million
Q4 2023

Feb 14, 2024

BUY
$57.25 - $69.74 $17.8 Million - $21.7 Million
310,594 Added 114.38%
582,150 $35 Million
Q2 2023

Aug 14, 2023

SELL
$46.28 - $75.01 $12.5 Million - $20.3 Million
-270,446 Reduced 49.9%
271,556 $18.7 Million
Q1 2023

May 15, 2023

BUY
$43.42 - $57.37 $7.9 Million - $10.4 Million
181,885 Added 50.51%
542,002 $26.1 Million
Q4 2022

Feb 14, 2023

SELL
$38.8 - $55.46 $12.7 Million - $18.2 Million
-327,581 Reduced 47.63%
360,117 $18 Million
Q3 2022

Nov 14, 2022

BUY
$38.15 - $57.1 $16.9 Million - $25.4 Million
444,096 Added 182.3%
687,698 $28.1 Million
Q2 2022

Aug 15, 2022

SELL
$33.54 - $55.0 $10.8 Million - $17.7 Million
-322,322 Reduced 56.95%
243,602 $13.4 Million
Q1 2022

May 16, 2022

BUY
$31.02 - $48.18 $12.8 Million - $19.9 Million
413,890 Added 272.24%
565,924 $20.6 Million
Q4 2021

Feb 14, 2022

BUY
$41.14 - $56.98 $54,592 - $75,612
1,327 Added 0.88%
152,034 $7.09 Million
Q3 2021

Nov 15, 2021

BUY
$35.31 - $50.56 $3.28 Million - $4.7 Million
92,867 Added 160.56%
150,707 $7.62 Million
Q2 2021

Aug 16, 2021

BUY
$25.8 - $41.09 $1.05 Million - $1.67 Million
40,666 Added 236.79%
57,840 $2.37 Million
Q1 2021

May 17, 2021

BUY
$23.55 - $32.4 $404,447 - $556,437
17,174 New
17,174 $498,000
Q4 2020

Feb 16, 2021

SELL
$25.8 - $32.39 $3.37 Million - $4.24 Million
-130,802 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$27.5 - $39.61 $4.14 Million - $5.96 Million
-150,444 Reduced 53.49%
130,802 $4.04 Million
Q2 2020

Aug 14, 2020

BUY
$36.1 - $42.56 $10.2 Million - $12 Million
281,246 New
281,246 $12 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.68B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.